You are here

Article Text

Article menu

Download PDFPDF

XML
Quality standards
British Thoracic Society Quality Standards for outpatient management of pulmonary embolism
  1. Robin Condliffe1,
  2. Paul Albert2,
  3. Raza Alikhan3,
  4. Emma Gee4,
  5. Daniel Horner5,
  6. Laura Hunter6,
  7. Phillip Jacobs7,
  8. Rachel Limbrey8,
  9. Michael Newnham9,
  10. Wendy Preston10,
  11. Sheena Patel11,
  12. Laura-Jane Smith12 and
  13. Jay Suntharalingam13
  1. 1Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
  2. 2Respiratory Medicine, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK
  3. 3Haematology, University Hospital of Wales, Cardiff, UK
  4. 4Thrombosis and Coagulation, King's College Hospital, London, UK
  5. 5Emergency Medicine, Salford Royal NHS Foundation Trust, Salford, UK
  6. 6Emergency Medicine, St Thomas' Hospital, London, UK
  7. 7Royal Free London NHS Foundation Trust, Barnet, UK
  8. 8Respiratory Medicine, Southampton General Hospital, Southampton, UK
  9. 9Respiratory Medicine, Papworth Hospital NHS Foundation Trust, Cambridge, Cambridgeshire, UK
  10. 10Respiratory Medicine, George Eliot Hospital NHS Trust, Nuneaton, Warwickshire, UK
  11. 11Anticoagulation and Medication Safety/Clinical Governance, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK
  12. 12Respiratory Medicine, Kings College Hospital, London, UK
  13. 13Respiratory Medicine, Royal United Hospital Bath NHS Trust, Bath, UK
  1. Correspondence to Dr Robin Condliffe; robin.condliffe{at}sth.nhs.uk

Abstract

Introduction The purpose of the quality standards document is to provide healthcare professionals, commissioners, service providers and patients with a guide to standards of care that should be met for outpatient management of pulmonary embolism in the UK, together with measurable markers of good practice. Quality statements are based on the British Thoracic Society (BTS) Guideline for the Initial Outpatient Management of Pulmonary Embolism.

Methods Development of BTS Quality Standards follows the BTS process of quality standard production based on the National Institute for Health and Care Excellence process manual for the development of quality standards.

Results Six quality statements have been developed, each describing a standard of care for the outpatient management of pulmonary embolism in the UK, together with measurable markers of good practice.

Discussion BTS Quality Standards for Outpatient Management of Pulmonary Embolism form a key part of the range of supporting materials that the society produces to assist in the dissemination and implementation of a guideline’s recommendations.

  • pulmonary embolism
http://creativecommons.org/licenses/by-nc/4.0/

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

https://doi.org/10.1136/bmjresp-2020-000636

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Contributors RC was the lead author responsible for the overall editing and production of the document. All authors were responsible for the final approval of the document.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests All authors completed a Declarations of Interest form in line with the BTS Policy for Declarations of Interest and forms are available on request from BTS Head Office. RC received funding from Actelion and MSD. PA received funding from Chiesi. RA received funding from Daiichi and from BMS, Pfizer and Bayer. RL received funding from Bayer and Actelion. MN received funding from MSD, GSK and Actelion. JS received funding from MSD, Chiesi, GSK, Teva and Johnson and Johnson. EG, LH, SP, WP, DH, LJS and PJ had no interests to declare.

    • Patient and public involvement Patients and/or the public were involved in the design, conduct, reporting or dissemination plans of this research. Refer to the 'Methods' section for further details.

    • Patient consent for publication Not required.

    • Provenance and peer review Not commissioned; internally peer reviewed.